| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/29/1999 | EP0944737A1 Representations of bimolecular interactions |
| 09/29/1999 | EP0944721A1 Adipocyte-specific differentiation-related protein |
| 09/29/1999 | EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/29/1999 | EP0944397A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 09/29/1999 | EP0944394A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/29/1999 | EP0944333A1 High moisture nutrient formulation for poultry |
| 09/29/1999 | EP0714307B1 Vaccine compositions |
| 09/29/1999 | EP0591281B1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 09/29/1999 | EP0474645B1 Protein complex |
| 09/29/1999 | CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies |
| 09/29/1999 | CN1230197A Subunit respiratory syncytial virus vaccine prepn. |
| 09/29/1999 | CN1230195A Treatment of immune disorders |
| 09/29/1999 | CN1229678A Chicken pest high immune liquid for treating Fashi cystoma and its prepn. method |
| 09/29/1999 | CN1045290C Method for preparation of chelans possesing ortho ligating functionality and complexes |
| 09/28/1999 | US5959092 These new isolates comprise nucleotide and amino acid sequences which are distinct from the prototype hcv isolate, hcv1. thus, j1 and j7 provide new polynucleotides and polypeptides for use, inter alia, in diagnostics, recombinant |
| 09/28/1999 | US5959083 Tetravalent bispecific receptors, the preparation and use thereof |
| 09/28/1999 | US5959079 CREBA isoform |
| 09/28/1999 | US5959075 Testis-specific insulin homolog polypeptides |
| 09/28/1999 | US5958971 Chemical compounds |
| 09/28/1999 | US5958895 Delivering to a mammalian cell an effective amount of a modified gene encoding an hsv gd antigen lacking a functional native signal peptide, said modified gene under the control of regulatory sequences directing expression of said antigen |
| 09/28/1999 | US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation |
| 09/28/1999 | US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof |
| 09/28/1999 | US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein |
| 09/28/1999 | US5958736 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 09/28/1999 | US5958734 Isolated polynucleotides and polypeptides of the glutamyl trna synthetase family (glus), vectors encoding them, host cells and methods for their production; use to screen for novel antibiotics |
| 09/28/1999 | US5958725 Human DP1 homolog |
| 09/28/1999 | US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 09/28/1999 | US5958718 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 09/28/1999 | US5958712 Identifying altered t cell receptor ligand comprising major histocompatible complex and peptide that inhibits t cell effector response |
| 09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
| 09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
| 09/28/1999 | US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer |
| 09/28/1999 | US5958457 Compositions for the delivery of antigens |
| 09/28/1999 | US5958425 Viral vaccines |
| 09/28/1999 | US5958424 Recombinant chicken anemia virus particle |
| 09/28/1999 | US5958423 Vaccine for immunizing animal against infection by bovine respiratory syncytial virus |
| 09/28/1999 | US5958422 Containing a foreign peptide insert in the coat protein of the virus; for use in vaccines |
| 09/28/1999 | US5958414 An isolated bartionella henselae antigen comprising whole inactivated bartionella henselae cells and an adjuvant comprising poly(di(carboxylatophenoxy)phosphazene; culture product |
| 09/28/1999 | US5958413 Pharmaceutical product for use in therapy or prophylaxis of disorders associated with elevated tumor necrosis factor levels, especially septic shock or endotoxic shock |
| 09/28/1999 | US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression |
| 09/28/1999 | US5958409 Administering antitumor necrosis factor antibody to the human suffering with multiple sclerosis |
| 09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
| 09/28/1999 | US5958405 Human protein tyrosine kinase |
| 09/28/1999 | CA2088354C Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 09/28/1999 | CA2072095C Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 09/26/1999 | CA2264260A1 Polynucleotide molecules encoding neospora proteins |
| 09/24/1999 | CA2249660A1 Novel compounds |
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047927A1 An equine neospora isolate and its uses |
| 09/23/1999 | WO1999047925A2 Methods and compositions for diagnosis of rheumatoid arthritis |
| 09/23/1999 | WO1999047707A1 Antisense modulation of lfa-3 |
| 09/23/1999 | WO1999047687A1 Enhanced anti-tumor immunity |
| 09/23/1999 | WO1999047680A1 Mutant recombinant allergens |
| 09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047667A1 Human sec61 gamma subunit gene: cbdame07 |
| 09/23/1999 | WO1999047665A1 THE HUMAN CI-B14.5a HOMOLOG GENE: CBUACD09 |
| 09/23/1999 | WO1999047664A1 The human mitochondrial proteolipid mp68 homolog gene: cbnaac01 |
| 09/23/1999 | WO1999047663A1 Human h-beta 58 gene (cblalc05) |
| 09/23/1999 | WO1999047662A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047657A2 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles |
| 09/23/1999 | WO1999047648A2 Medium and method for viral propagation and growth |
| 09/23/1999 | WO1999047646A1 Processes for improved presentation of antigens by dendritic cells |
| 09/23/1999 | WO1999047645A1 Process for the production of virus in cell cultures |
| 09/23/1999 | WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | WO1999047639A2 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047558A2 T cell costimulatory proteins, sequences and uses thereof |
| 09/23/1999 | WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 09/23/1999 | WO1999047544A1 nrdF |
| 09/23/1999 | WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 09/23/1999 | WO1999047179A1 COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN DELIVERY TO ANTIGEN PRESENTING CELLS $i(IN VIVO) |
| 09/23/1999 | WO1999047170A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists |
| 09/23/1999 | WO1999047169A1 Methods to provoke anti-cancer immune responses |
| 09/23/1999 | WO1999047168A2 Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties |
| 09/23/1999 | WO1999047167A1 Double mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047165A1 Production of purified mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047164A1 Use of mutant enterotoxin with excess b-subunit as an adjuvant |
| 09/23/1999 | WO1999047163A2 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/23/1999 | WO1999047162A1 Products in the treatment of cancer |
| 09/23/1999 | WO1999047147A1 nrdG |
| 09/23/1999 | WO1999047109A1 Sun-protection formulations active against herpes simplex viruses |
| 09/23/1999 | WO1999046992A1 Induction of immunity against tumor self-antigens |
| 09/23/1999 | WO1999046988A1 Compositions and methods for antigen-specific vaccination |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999041355A3 Hiv chemokines |
| 09/23/1999 | WO1999039736A3 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
| 09/23/1999 | WO1999039693A3 Methods and compositions for detection and diagnosis of infectious diseases |
| 09/23/1999 | WO1999037774A8 Differentiation-associated sequences and methods of use therefor |
| 09/23/1999 | WO1999036433A3 Materials and methods for treating oncological disease |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | WO1999027944A9 Prevention and treatment of amyloidogenic disease |
| 09/23/1999 | WO1998015284A3 Mycosis vaccines |
| 09/23/1999 | DE19811692A1 Sunscreen formulation containing filters preventing herpes virus activation and herpetic skin disease |
| 09/23/1999 | DE19802139C1 Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung A monoclonal antibody specific for activated coagulation factor VII and its use |
| 09/23/1999 | CA2324337A1 Products in the treatment of cancer |
| 09/23/1999 | CA2323746A1 T cell costimulatory proteins, sequences and uses thereof |
| 09/23/1999 | CA2323724A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | CA2323634A1 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles |